Emboline expects that its technology designed to reduce stroke risk during structural heart procedures will launch in the US and Europe later this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results